Medpace Holdings, Inc. is a clinical contract research organization. The Company provides clinical research-based drug and medical device development services. The Company partners with pharmaceutical, biotechnology, and medical device companies in the development and execution of clinical trials. The Company's drug development services focus on full service Phase I-IV clinical development services and include development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support. The Company also provides bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The Company's operations are principally based in North America, Europe, and Asia.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: Biotechnology & Medical Research
- Sub-Industry: N/A
- Symbol: NASDAQ:MEDP
- CUSIP: N/A
- Web: www.medpace.com
- Market Cap: $1.23436 billion
- Outstanding Shares: 39,487,000
- 50 Day Moving Avg: $31.55
- 200 Day Moving Avg: $28.95
- 52 Week Range: $21.76 - $38.94
Sales & Book Value:
- Trailing P/E Ratio: 55.04
- Foreward P/E Ratio: 19.14
- P/E Growth: 1.94
- Annual Revenue: $378.52 million
- Price / Sales: 3.25
- Book Value: $15.30 per share
- Price / Book: 2.04
- EBIDTA: $110.08 million
- Net Margins: 5.37%
- Return on Equity: 9.32%
- Return on Assets: 5.88%
- Debt-to-Equity Ratio: 0.28%
- Current Ratio: 0.79%
- Quick Ratio: 0.79%
- Average Volume: 166,470 shs.
- Short Ratio: 3.91
Frequently Asked Questions for Medpace Holdings (NASDAQ:MEDP)
What is Medpace Holdings' stock symbol?
Medpace Holdings trades on the NASDAQ under the ticker symbol "MEDP."
How were Medpace Holdings' earnings last quarter?
Medpace Holdings, Inc. (NASDAQ:MEDP) issued its quarterly earnings results on Monday, July, 31st. The company reported $0.38 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.30 by $0.08. The business had revenue of $94.60 million for the quarter, compared to analyst estimates of $92.71 million. Medpace Holdings had a net margin of 5.37% and a return on equity of 9.32%. The business's revenue was up 2.1% compared to the same quarter last year. During the same period in the previous year, the business posted $0.45 earnings per share. View Medpace Holdings' Earnings History.
When will Medpace Holdings make its next earnings announcement?
What guidance has Medpace Holdings issued on next quarter's earnings?
Medpace Holdings issued an update on its FY17 earnings guidance on Monday, July, 31st. The company provided earnings per share (EPS) guidance of $1.36-1.46 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $1.35. The company issued revenue guidance of $373-385 million, compared to the consensus revenue estimate of $376.90 million.
Where is Medpace Holdings' stock going? Where will Medpace Holdings' stock price be in 2017?
4 brokerages have issued twelve-month price targets for Medpace Holdings' stock. Their predictions range from $31.00 to $36.00. On average, they anticipate Medpace Holdings' share price to reach $33.67 in the next twelve months. View Analyst Ratings for Medpace Holdings.
What are analysts saying about Medpace Holdings stock?
Here are some recent quotes from research analysts about Medpace Holdings stock:
- 1. According to Zacks Investment Research, "Medpace Holdings, Inc. is a scientifically-driven, global, full-service clinical contract research organization which provides Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace Holdings, Inc. is headquartered in Cincinnati, Ohio. " (9/9/2017)
- 2. Jefferies Group LLC analysts commented, "Medpace boasts eye-popping margin, strong cash flow, and an enticing correlation to fast growing biotech customers. With its group-high valuation, MEDP's risk, in our view, is that investors have looked through management's "conservative" guidance to upsides, akin to prior CRO post-IPO performances. 1.05x BtB, lower 2017 revenue guidance, and in-line EPS will likely pressure the stock a little on Tuesday." (2/28/2017)
Who are some of Medpace Holdings' key competitors?
Some companies that are related to Medpace Holdings include Blueprint Medicines Corporation (BPMC), Ironwood Pharmaceuticals (IRWD), Sage Therapeutics (SAGE), Intrexon Corporation (XON), Immunomedics (IMMU), Foundation Medicine (FMI), Biohaven Pharmaceutical Holding Co Ltd (BHVN), Esperion Therapeutics (ESPR), Momenta Pharmaceuticals (MNTA), Genus plc (GNS), Global Blood Therapeutics (GBT), Genomic Health (GHDX), Cellectis S.A. (CLLS), Arena Pharmaceuticals (ARNA), Albany Molecular Research (AMRI), Editas Medicine (EDIT), BeyondSpring (BYSI) and Enanta Pharmaceuticals (ENTA).
Who are Medpace Holdings' key executives?
Medpace Holdings' management team includes the folowing people:
- August J. Troendle M.D., Chairman of the Board, President, Chief Executive Officer
- Jesse J. Geiger CPA, Chief Financial Officer, Chief Operating Officer - Laboratory Operations
- Susan E. Burwig, Executive Vice President - Operations
- Penelope J. Bucknell, Vice President - Human Resources
- Stephen P. Ewald J.D., General Counsel, Corporate Secretary
- Anastasya Molodykh, Director
- John R. Richardson, Director
- Bruce Brown, Independent Director
- Brian T. Carley, Independent Director
- Robert O. Kraft, Independent Director
When did Medpace Holdings IPO?
(MEDP) raised $150 million in an IPO on Thursday, August 11th 2016. The company issued 7,000,000 shares at a price of $20.00-$23.00 per share. Jefferies, Credit Suisse, UBS Investment Bank and Wells Fargo Securities acted as the underwriters for the IPO and Baird and William Blair were co-managers.
Who owns Medpace Holdings stock?
Medpace Holdings' stock is owned by many different of institutional and retail investors. Top institutional shareholders include
CINVEN CAPITAL MANAGEMENT (V) GENERAL PARTNER LTD
CINVEN CAPITAL MANAGEMENT (V) GENERAL PARTNER LTD
(56.00%), Vanguard Group Inc. (2.57%), Bernzott Capital Advisors (1.46%), Acadian Asset Management LLC (1.19%) and Granite Investment Partners LLC (0.69%). Company insiders that own Medpace Holdings stock include August J Troendle, Medpace Limited Partnership and Susan E Burwig. View Institutional Ownership Trends for Medpace Holdings.
Who sold Medpace Holdings stock? Who is selling Medpace Holdings stock?
Medpace Holdings' stock was sold by a variety of institutional investors in the last quarter, including TIAA CREF Investment Management LLC, Citadel Advisors LLC, Spark Investment Management LLC, Teachers Advisors LLC, Russell Investments Group Ltd., Wells Fargo & Company MN, California State Teachers Retirement System and OxFORD Asset Management LLP. View Insider Buying and Selling for Medpace Holdings.
Who bought Medpace Holdings stock? Who is buying Medpace Holdings stock?
Medpace Holdings' stock was acquired by a variety of institutional investors in the last quarter, including Bernzott Capital Advisors, Granite Investment Partners LLC, Redmile Group LLC, Ameriprise Financial Inc., Vanguard Group Inc., Acadian Asset Management LLC, Fisher Asset Management LLC and Prudential Financial Inc.. Company insiders that have bought Medpace Holdings stock in the last two years include August J Troendle and Susan E Burwig. View Insider Buying and Selling for Medpace Holdings.
How do I buy Medpace Holdings stock?
Shares of Medpace Holdings can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Medpace Holdings' stock price today?
MarketBeat Community Rating for Medpace Holdings (NASDAQ MEDP)MarketBeat's community ratings are surveys of what our community members think about Medpace Holdings and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
One share of Medpace Holdings stock can currently be purchased for approximately $31.20.
Consensus Ratings for Medpace Holdings (NASDAQ:MEDP) (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Ratings Breakdown: ||2 Hold Ratings, 2 Buy Ratings|
|Consensus Rating:||Buy (Score: 2.50)|
|Consensus Price Target: ||$33.67 (7.91% upside)|
Analysts' Ratings History for Medpace Holdings (NASDAQ:MEDP)
(Data available from 9/20/2015 forward)
|Date||Firm||Action||Rating||Price Target||Impact on Share Price||Details|
|8/2/2017||Jefferies Group LLC||Reiterated Rating||Hold||$30.00 -> $31.00||Low|
|6/6/2017||Credit Suisse Group||Reiterated Rating||Outperform||$35.00 -> $36.00||Low|
|5/3/2017||Wells Fargo & Company||Downgrade||Outperform -> Market Perform||High|
|3/29/2017||KeyCorp||Initiated Coverage||Overweight -> Overweight||$34.00||Medium|
|9/6/2016||William Blair||Reiterated Rating||Outperform||N/A|
|9/6/2016||Robert W. Baird||Initiated Coverage||Neutral||$35.00||N/A|
Earnings History for Medpace Holdings (NASDAQ:MEDP)Earnings History by Quarter for Medpace Holdings (NASDAQ MEDP)
(Data available from 1/1/2011 forward)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|7/31/2017||Q2 2017||$0.30||$0.38||$92.71 million||$94.60 million||View||N/A|
|5/1/2017||Q1 2017||$0.37||$0.34||$93.61 million||$93.80 million||View||Listen|
|2/27/2017||Q416||$0.34||$0.35||$94.40 million||$95.38 million||View||Listen|
|11/3/2016||Q316||$0.34||$0.40||$91.42 million||$94.80 million||View||Listen|
Earnings Estimates for Medpace Holdings (NASDAQ:MEDP)
2017 EPS Consensus Estimate: $1.40
2018 EPS Consensus Estimate: $1.62
(Data provided by Zacks Investment Research)
|Quarter||Number of Estimates||Low Estimate||High Estimate||Average Estimate|
Dividend History for Medpace Holdings (NASDAQ:MEDP)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading and Institutional Ownership History for Medpace Holdings (NASDAQ:MEDP)
Insider Ownership Percentage: 25.80%Insider Trades by Quarter for Medpace Holdings (NASDAQ:MEDP)
Institutional Ownership Percentage: 15.98%
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Details|
|8/22/2017||Medpace Limited Partnership||Major Shareholder||Sell||2,000,000||$30.27||$60,540,000.00|| |
|8/18/2016||August J Troendle||CEO||Buy||10,000||$27.98||$279,800.00|| |
|8/17/2016||Susan E Burwig||Insider||Buy||19,211||$29.21||$561,153.31|| |
|8/16/2016||August J Troendle||CEO||Buy||869,565||$23.00||$19,999,995.00|| |
Headline Trends for Medpace Holdings (NASDAQ:MEDP)
Latest Headlines for Medpace Holdings (NASDAQ:MEDP)
|Medpace Holdings, Inc. (MEDP) Given Consensus Rating of "Buy" by Analysts|
www.americanbankingnews.com - September 17 at 2:50 AM
|Medpace Holdings, Inc. (MEDP) Upgraded to Strong-Buy at Zacks Investment Research|
www.americanbankingnews.com - September 9 at 9:26 AM
|Medpace Holdings, Inc. (MEDP) Expected to Post Quarterly Sales of $95.10 Million|
www.americanbankingnews.com - September 7 at 7:38 AM
|BRIEF-Medpace Holdings files for mixed shelf of up to $75 million |
www.reuters.com - September 2 at 7:36 PM
|Medpace Holdings, Inc. to Present at Wells Fargo Healthcare Conference|
finance.yahoo.com - August 24 at 9:08 AM
|Medpace Holdings, Inc. (MEDP) Given Average Recommendation of "Hold" by Brokerages|
www.americanbankingnews.com - August 23 at 3:32 AM
|Insider Selling: Medpace Holdings, Inc. (MEDP) Major Shareholder Sells 2,000,000 Shares of Stock|
www.americanbankingnews.com - August 22 at 7:16 PM
|Medpace Holdings (MEDP) & Voyager Therapeutics (VYGR) Head to Head Analysis|
www.americanbankingnews.com - August 21 at 10:26 AM
|Zacks: Analysts Anticipate Medpace Holdings, Inc. (MEDP) Will Announce Quarterly Sales of $95.10 Million|
www.americanbankingnews.com - August 20 at 7:16 AM
|BRIEF-Medpace Holdings announces stock repurchase agreement with Cinven|
www.reuters.com - August 18 at 6:42 AM
|ETFs with exposure to Medpace Holdings, Inc. : August 16, 2017|
finance.yahoo.com - August 17 at 2:32 AM
|Medpace Holdings, Inc. Announces Stock Repurchase Agreement with Cinven|
finance.yahoo.com - August 17 at 2:32 AM
|Medpace Holdings, Inc. :MEDP-US: Earnings Analysis: Q2, 2017 By the Numbers : August 4, 2017|
finance.yahoo.com - August 5 at 2:45 AM
|FY2019 EPS Estimates for Medpace Holdings, Inc. Raised by William Blair (NASDAQ:MEDP)|
www.americanbankingnews.com - August 4 at 7:40 PM
|FY2017 EPS Estimates for Medpace Holdings, Inc. Raised by William Blair (MEDP)|
www.americanbankingnews.com - August 3 at 9:50 AM
|Medpace Holdings, Inc. (MEDP) Receives Hold Rating from Jefferies Group LLC|
www.americanbankingnews.com - August 2 at 4:38 PM
|Zacks: Analysts Expect Medpace Holdings, Inc. (NASDAQ:MEDP) Will Post Quarterly Sales of $95.59 Million|
www.americanbankingnews.com - August 2 at 8:26 AM
|Jefferies Group Analysts Increase Earnings Estimates for Medpace Holdings, Inc. (MEDP)|
www.americanbankingnews.com - August 2 at 7:02 AM
|Edited Transcript of MEDP earnings conference call or presentation 1-Aug-17 1:00pm GMT|
finance.yahoo.com - August 2 at 5:09 AM
|Head-To-Head Contrast: Zynerba Pharmaceuticals (ZYNE) & Medpace Holdings (MEDP)|
www.americanbankingnews.com - August 1 at 8:30 PM
|Medpace Holdings, Inc. (NASDAQ:MEDP) Announces Earnings Results|
www.americanbankingnews.com - July 31 at 9:10 PM
|Medpace Holdings, Inc. Reports Second Quarter 2017 Results|
finance.yahoo.com - July 31 at 8:09 PM
|Medpace tops Street 2Q forecasts|
finance.yahoo.com - July 31 at 8:09 PM
|Medpace Holdings, Inc. (NASDAQ:MEDP) Updates FY17 Earnings Guidance|
www.americanbankingnews.com - July 31 at 6:06 PM
|Medpace Holdings, Inc. (MEDP) Receives Average Rating of "Hold" from Brokerages|
www.americanbankingnews.com - July 29 at 7:27 AM
|Medpace Holdings, Inc. breached its 50 day moving average in a Bearish Manner : MEDP-US : July 28, 2017|
finance.yahoo.com - July 28 at 4:02 PM
|ETFs with exposure to Medpace Holdings, Inc. : July 27, 2017|
finance.yahoo.com - July 28 at 3:56 AM
|Financial Analysis: Nektar Therapeutics (NKTR) versus Medpace Holdings (NASDAQ:MEDP)|
www.americanbankingnews.com - July 22 at 8:22 PM
|ETFs with exposure to Medpace Holdings, Inc. : July 17, 2017|
finance.yahoo.com - July 17 at 6:20 PM
|Medpace Holdings, Inc. breached its 50 day moving average in a Bullish Manner : MEDP-US : July 12, 2017|
finance.yahoo.com - July 13 at 6:42 AM
|Q4 2017 EPS Estimates for Medpace Holdings, Inc. Increased by KeyCorp (MEDP)|
www.americanbankingnews.com - July 12 at 12:55 PM
|Medpace Holdings, Inc. (NASDAQ:MEDP) Downgraded by Zacks Investment Research to Sell|
www.americanbankingnews.com - July 12 at 7:32 AM
|Medpace Holdings, Inc. to Report Second Quarter 2017 Financial Results on July 31, 2017|
finance.yahoo.com - July 12 at 3:26 AM
|Q2 2017 Earnings Forecast for Medpace Holdings, Inc. (MEDP) Issued By KeyCorp|
www.americanbankingnews.com - July 11 at 8:04 AM
|Medpace Holdings, Inc. (MEDP) Cut to "Overweight" at KeyCorp|
www.americanbankingnews.com - July 10 at 7:52 AM
|Medpace Holdings, Inc. (MEDP) Upgraded by Zacks Investment Research to "Hold"|
www.americanbankingnews.com - July 9 at 11:32 PM
|Zacks: Analysts Expect Medpace Holdings, Inc. (NASDAQ:MEDP) Will Announce Quarterly Sales of $93.58 Million|
www.americanbankingnews.com - July 8 at 7:36 AM
|$0.30 Earnings Per Share Expected for Medpace Holdings, Inc. (MEDP) This Quarter|
www.americanbankingnews.com - July 6 at 10:14 PM
|ETFs with exposure to Medpace Holdings, Inc. : July 5, 2017|
finance.yahoo.com - July 5 at 4:22 PM
|Medpace Holdings, Inc. (NASDAQ:MEDP) Receives Average Recommendation of "Hold" from Analysts|
www.americanbankingnews.com - July 4 at 10:02 AM
|Medpace Holdings, Inc. (MEDP) to Post Q1 2018 Earnings of $0.37 Per Share, Jefferies Group Forecasts|
www.americanbankingnews.com - June 30 at 9:42 AM
|BRIEF-Medpace Holdings says Medpace Limited Partnership entered into credit agreement|
www.businessinsider.com - June 24 at 4:58 AM
|Medpace Holdings, Inc. (MEDP) Expected to Announce Earnings of $0.30 Per Share|
www.americanbankingnews.com - June 15 at 2:06 PM
|$93.58 Million in Sales Expected for Medpace Holdings, Inc. (MEDP) This Quarter|
www.americanbankingnews.com - June 14 at 9:36 AM
|Medpace Holdings, Inc. breached its 50 day moving average in a Bearish Manner : MEDP-US : June 12, 2017|
finance.yahoo.com - June 12 at 9:21 AM
|Medpace Holdings Inc (MEDP) Given Average Recommendation of "Hold" by Brokerages|
www.americanbankingnews.com - June 9 at 11:24 AM
|ETFs with exposure to Medpace Holdings, Inc. : June 8, 2017|
finance.yahoo.com - June 8 at 7:27 PM
|Medpace Holdings Inc (MEDP) Given "Outperform" Rating at Credit Suisse Group AG|
www.americanbankingnews.com - June 6 at 3:38 PM
|Medpace Holdings, Inc. to Present at Two Upcoming Investor Conferences|
finance.yahoo.com - June 1 at 7:18 PM
|Medpace Holdings, Inc. breached its 50 day moving average in a Bullish Manner : MEDP-US : June 1, 2017|
finance.yahoo.com - June 1 at 9:27 AM
Medpace Holdings (MEDP) Chart for Wednesday, September, 20, 2017